|
|
Volumn 296, Issue 5577, 2002, Pages 2322-
|
|
Therapies. Raising the limits.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
PEPTIDE FRAGMENT;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ARTICLE;
CLINICAL TRIAL;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CLINICAL TRIALS;
HIV ENVELOPE PROTEIN GP41;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
PEPTIDE FRAGMENTS;
REVERSE TRANSCRIPTASE INHIBITORS;
|
|
EID: 19044387614
PISSN: None
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.296.5577.2322 Document Type: Article |
|
Times cited : (7)
|
|
References (0)
|
